Ampicillin Sodium

氨苄西林钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmpicillin Sodium
Drug Alias NameAmpicilino natrio druskaAmpicillinum natricumAminobenzylpenicillin SodiumSodyum AmpisilinNatrii Ampicillinum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1961/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline PlcPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Jiu'An Pharmaceutical Co LtdTianjin Tianan Pharmaceutical Co Ltd
Inactive CompaniesWyeth-Ayerst
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CA01S01AA19
Related LinksWikipediaDrugBankKEGG